Saturday, June 27, 2026

SBE303: The Next-Gen ADC Cancer Drug Revolutionizing Treatment in 2026

Samsung Bioepis presents promising results for SBE303, a next-gen ADC targeting nectin-4, showing improved efficacy and safety in trials.

‘NVIDIA Shock’ Sends Semiconductor Stocks Into a Downturn

The South Korean stock market started with a decline, including a nearly 6% drop in NVIDIA, in the aftermath of the mixed employment...

Sam Altman Fires Back at New York Times in AI Copyright Clash

Sam Altman criticizes The New York Times' lawsuit against OpenAI, highlighting tensions between AI firms and traditional media over data use.

CARS

TECH

FUTURE

HEALTH

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.